Market Research Logo

Cardiovascular Drugs Market covering Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs); Global Briefing 2019

Cardiovascular Drugs Market covering Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs); Global Briefing 2019

North America was the largest region in the cardiovascular drugs market worth $43.3 billion in 2018, accounting for 40.6% of the global cardiovascular drugs market, followed by Asia Pacific at 31.4% and Western Europe at 13.3% respectively.

Cardiovascular Drugs Market covering Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs); Global Briefing 2019 provides strategists, marketers and senior management with the critical information they need to assess the global cardiovascular drugs sector.

Reasons to Purchase

  • Fully updated for 2019.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.
Description

Cardiovascular Drugs Market covering Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs); Global Briefing 2019 from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the cardiovascular drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the cardiovascular drugs market and suggests approaches.

Scope

Markets Covered: Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)

Companies Mentioned: Bristol-Myers Squibb; Sanofi S.A.; Johnson & Johnson; Astrazeneca; Novartis AG

Geographic scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East, Africa

Countries: Australia, China, Hong Kong, India, Indonesia, Japan, South Korea, Malaysia, New Zealand, Philippines, Singapore, Thailand, Vietnam, Canada, USA, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, the UK, Czech Republic, Poland, Romania, Russia, Israel, Saudi Arabia, Turkey, UAE, Egypt, Nigeria, South Africa

Time series: Five years historic and forecast

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


Cardiovascular Drugs Market Characteristics
Cardiovascular Drugs Market Trends And Strategies
Novel Oral Anti-coagulants (NOACs) To Prevent Thrombosis
Approval Of New Drugs For Treatment Of Chronic Heart Failure
Personalized Medicine For Treatment Of Cardiovascular Disorders
Big Data
Data Generated From Wearables Driving Innovation For Cardiovascular Diseases
Collaboration Driving Innovation For Cardiovascular Diseases
MicroRNA-Based Therapeutics In Cardiovascular Disease
Cardiovascular Drugs Market Historic Growth
Cardiovascular Drugs Market Forecast Growth
Cardiovascular Drugs Market Segmentation
Global Cardiovascular Drugs Market, Split By Segment, 2018, $ Billion
Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)
Anti-Hypertensive Drugs
Anti Thrombotics
Global Cardiovascular Drugs Market, Historic And Forecast, Split By Segment, 2014-2022
Cardiovascular Drugs Market Geography Regional Comparison
Global Cardiovascular Drugs Market, Split By Region, 2018, $ Billion
Global Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2014-2022
Asia Pacific Cardiovascular Drugs Market Analysis
Asia Pacific Cardiovascular Drugs Market, 2014 – 2022
Asia Pacific Cardiovascular Drugs Market, Split By Country, 2018
Asia Pacific Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
Asia Pacific Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018
North America Cardiovascular Drugs Market Analysis
North America Cardiovascular Drugs Market, 2014 – 2022
North America Cardiovascular Drugs Market, Split By Country, 2018
North America Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
North America Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018
Western Europe Cardiovascular Drugs Market Analysis
Western Europe Cardiovascular Drugs Market, 2014 – 2022
Western Europe Cardiovascular Drugs Market, Split By Country, 2018
Western Europe Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
Western Europe Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018
Eastern Europe Cardiovascular Drugs Market Analysis
Eastern Europe Cardiovascular Drugs Market, 2014 – 2022
Eastern Europe Cardiovascular Drugs Market, Split By Country, 2018
Eastern Europe Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
Eastern Europe Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018
South America Cardiovascular Drugs Market Analysis
South America Cardiovascular Drugs Market, 2014 – 2022
South America Cardiovascular Drugs Market, Split By Country, 2018
South America Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
South America Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018
Africa Cardiovascular Drugs Market Analysis
Africa Cardiovascular Drugs Market, 2014 – 2022
Africa Cardiovascular Drugs Market, Split By Country, 2018
Africa Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
Africa Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018
Middle East Cardiovascular Drugs Market Analysis
Middle East Cardiovascular Drugs Market, 2014 – 2022
Middle East Cardiovascular Drugs Market, Split By Country, 2018
Middle East Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
Middle East Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018
Cardiovascular Drugs Market Competitive Landscape
Bristol-Myers Squibb
Sanofi S.A
Johnson & Johnson
Astrazeneca
Novartis AG
Cardiovascular Drugs Market, Key Mergers And Acquisitions
Teva Acquired Allergan’s Generic Business
Janssen Holding Acquired Actelion
Pfizer Acquired Hospira
Mylan Acquired Stake in Meda
AstraZeneca Acquired ZS Pharma
AstraZeneca Acquired Omthera Pharmaceuticals
Bristol-Myers Squibb Acquired Cardioxyl Pharmaceuticals
Appendix
Market Data Sources
NAICS Definitions Of Industry Covered In This Report
Research Methodology
Abbreviations
Currencies
Research Inquiries
The Business Research Company
Copyright And Disclaimer
List of Tables
Table 1: Global Cardiovascular Drugs Market, Historic Market Size, 2014-2018, $ Billion 12
Table 2: Global Cardiovascular Drugs Market, Forecast Market Size, 2018-2022, $ Billion 13
Table 3: Global Cardiovascular Drugs Market, Split By Segment, 2018, $ Billion 14
Table 4: Global Cardiovascular Drugs Market, Historic And Forecast, Split By Segment, 2014-2022 16
Table 5: Global Cardiovascular Drugs Market, Split By Region, 2018, $ Billion 18
Table 6: Global Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2014-2022 20
Table 7: Asia Pacific Cardiovascular Drugs Market, 2014-2022, $ Billion 22
Table 8: Asia Pacific Cardiovascular Drugs Market, Split By Country, 2018, $ Billion 24
Table 9: Asia Pacific Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 26
Table 10: Asia Pacific Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018 28
Table 11: North America Cardiovascular Drugs Market, 2014-2022, $ Billion 30
Table 12: North America Cardiovascular Drugs Market, Split By Country, 2018, $ Billion 31
Table 13: North America Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 33
Table 14: North America Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018 34
Table 15: Western Europe Cardiovascular Drugs Market, 2014-2022, $ Billion 36
Table 16: Western Europe Cardiovascular Drugs Market, Split By Country, 2018, $ Billion 38
Table 17: Western Europe Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 40
Table 18: Western Europe Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018 42
Table 19: Eastern Europe Cardiovascular Drugs Market, 2014-2022, $ Billion 44
Table 20: Eastern Europe Cardiovascular Drugs Market, Split By Country, 2018, $ Billion 46
Table 21: Eastern Europe Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 48
Table 22: Eastern Europe Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018 49
Table 23: South America Cardiovascular Drugs Market, 2014-2022, $ Billion 51
Table 24: South America Cardiovascular Drugs Market, Split By Country, 2018, $ Billion 53
Table 25: South America Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 55
Table 26: South America Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018 57
Table 27: Africa Cardiovascular Drugs Market, 2014-2022, $ Billion 59
Table 28: Africa Cardiovascular Drugs Market, Split By Country, 2018, $ Billion 61
Table 29: Africa Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 63
Table 30: Africa Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018 64
Table 31: Middle East Cardiovascular Drugs Market, 2014-2022, $ Billion 66
Table 32: Middle East Cardiovascular Drugs Market, Split By Country, 2018, $ Billion 68
Table 33: Middle East Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 70
Table 34: Middle East Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018 71
Table 35: Global Cardiovascular Drugs Market, Key Competitors Estimated Market Shares, 2018, Percentage (%) 73
Table 36: Cardiovascular Drugs Market Data Sources 78
List of Figures
Figure 1: Global Cardiovascular Drugs Market, Historic Market Size, 2014-2018, $ Billion
Figure 2: Global Cardiovascular Drugs Market, Forecast Market Size, 2018-2022, $ Billion
Figure 3: Global Cardiovascular Drugs Market, Split By Segment, 2018, $ Billion
Figure 4: Global Cardiovascular Drugs Market, Historic And Forecast, Split By Segment, 2014-2022
Figure 5: Global Cardiovascular Drugs Market, Split By Region, 2018, $ Billion
Figure 6: Global Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2014-2022
Figure 7: Asia Pacific Cardiovascular Drugs Market, 2014-2022, $ Billion
Figure 8: Asia Pacific Cardiovascular Drugs Market, Split By Country, 2018, $ Billion
Figure 9: Asia Pacific Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022
Figure 10: Asia Pacific Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018
Figure 11: North America Cardiovascular Drugs Market, 2014-2022, $ Billion
Figure 12: North America Cardiovascular Drugs Market, Split By Country, 2018, $ Billion
Figure 13: North America Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022
Figure 14: North America Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018
Figure 15: Western Europe Cardiovascular Drugs Market, 2014-2022, $ Billion
Figure 16: Western Europe Cardiovascular Drugs Market, Split By Country, 2018, $ Billion
Figure 17: Western Europe Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022
Figure 18: Western Europe Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018
Figure 19: Eastern Europe Cardiovascular Drugs Market, 2014-2022, $ Billion
Figure 20: Eastern Europe Cardiovascular Drugs Market, Split By Country, 2018, $ Billion
Figure 21: Eastern Europe Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022
Figure 22: Eastern Europe Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018
Figure 23: South America Cardiovascular Drugs Market, 2014-2022, $ Billion
Figure 24: South America Cardiovascular Drugs Market, Split By Country, 2018, $ Billion
Figure 25: South America Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022
Figure 26: South America Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018
Figure 27: Africa Cardiovascular Drugs Market, 2014-2022, $ Billion
Figure 28: Africa Cardiovascular Drugs Market, Split By Country, 2018, $ Billion
Figure 29: Africa Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022
Figure 30: Africa Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018
Figure 31: Middle East Cardiovascular Drugs Market, 2014-2022, $ Billion
Figure 32: Middle East Cardiovascular Drugs Market, Split By Country, 2018, $ Billion
Figure 33: Middle East Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022
Figure 34: Middle East Cardiovascular Drugs Market, Per Capita Average Expenditure, By Country, 2018
Figure 35: Global Cardiovascular Drugs Market, Key Competitor Estimated Market Shares, 2018, Percentage (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report